|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income (loss) to net cash (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Accrued loss on long-term contract | |||||
| Increase (Decrease) in Deferred Income Taxes | |||||
| Retirement benefit plans (gains) losses, net | |||||
| Revaluation of inventory borrowing | |||||
| Gain (Loss) on Extinguishment of Debt | |||||
| Equity Related Compensation | |||||
| Amortization of Debt Discount (Premium) | |||||
| Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Other Item | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable – (increase) decrease | |||||
| Increase (Decrease) in Inventories | |||||
| Increase Decrease in Inventories Owed to Suppliers | |||||
| Increase (Decrease) in Other Current Assets | |||||
| Payables under SWU purchase agreements – increase (decrease) | |||||
| Deferred revenue, net of deferred costs – increase (decrease) | |||||
| Accounts payable and other liabilities – increase (decrease) | |||||
| Pension and postretirement liabilities - increase (decrease) | |||||
| Other, net | |||||
| Net cash used in operating activities | |||||
| Cash Flows Provided by Investing Activities | |||||
| Capital expenditures | |||||
| Cash Provided by (Used in) Investing Activity, Including Discontinued Operation | |||||
| Cash Flows Used in Financing Activities | |||||
| Proceeds from the sale of common stock, net | |||||
| Repayments of Debt | |||||
| Debt Instrument, Repaid, Principal | |||||
| Exercise of stock options | |||||
| Shares withheld for employee taxes | |||||
| Proceeds from (Payment for) Other Financing Activity | |||||
| Net cash used in financing activities | |||||
| Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | |||||
| Decrease in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, start of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Supplemental Cash Flow Information: | |||||
| Other Significant Noncash Transaction, Value of Consideration Given | |||||
| Property, plant and equipment included in accounts payable and accrued liabilities | |||||
| Equity issuance costs included in accounts payable and accrued liabilities | |||||
| Disposal of right to use lease assets | |||||
| Reclassification of equity compensation liability to equity | |||||
| Common stock and warrant issued in exchange for preferred stock | |||||
| Equity issuance costs included in accounts payable and accrued liabilities | |||||
| Income Taxes Paid, Net | |||||
| Proceeds from Convertible Debt | |||||
| Income Tax Paid, Federal, after Refund Received | |||||
| Income Tax Paid, State and Local, after Refund Received | |||||
| MARYLAND | |||||
| NEW YORK | |||||
| Total income Tax Paid, State and Local, after Refund Received | |||||
| Income Tax Paid, Foreign, after Refund Received | |||||
| Interest Paid, Including Capitalized Interest, Operating and Investing Activities | |||||
Loading...